Status:
ACTIVE_NOT_RECRUITING
Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome
Lead Sponsor:
Vanderbilt University
Conditions:
Postural Orthostatic Tachycardia Syndrome
Eligibility:
All Genders
13-80 years
Brief Summary
In this pilot study, the investigators will test the hypothesis that patients with postural tachycardia syndrome will have an elevated percentage of functional antibodies to adrenergic receptors compa...
Detailed Description
Postural orthostatic tachycardia syndrome is poorly understood. Many of these patients have elevated levels of plasma norepinephrine, particularly when upright One subgroup of patients has a primary h...
Eligibility Criteria
Inclusion
- Postural Tachycardia Syndrome
- Previously diagnosed with POTS
- Control Subjects
- Not diagnosed with POTS
- Age between 13-80 years
- Male and female subjects are eligible.
- Able and willing to provide informed consent
Exclusion
- Inability to give, or withdrawal of, informed consent
- Other factors which in the investigator's opinion would prevent the subject from completing the protocol.
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2029
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT02196376
Start Date
July 1 2014
End Date
July 1 2029
Last Update
October 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232